Levodopa reduces risk factors for vascular disease in parkinsonian patients

被引：0
|
作者：
G. Scigliano
G. Ronchetti
F. Girotti
M. Musicco
机构：
[1] Istituto Nazionale Neurologico “C. Besta”,Institute of Biomedical Technologies
[2] National Research Council,undefined
[3] Fondazione S. Lucia,undefined
[4] Istituto Nazionale Neurologico “C. Besta”,undefined
来源：
Journal of Neurology | 2008年 / 255卷
关键词：
Levodopa; Daily Levodopa Dose; Inhibit Norepinephrine Release; Post Ganglionic Sympathetic Nerve;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Hemodynamic Correlates of Vascular Risk Factors in Patients with Alzheimer's Disease
    Yamazaki, Takashi
    Takano, Daiki
    Nagata, Ken
    NEUROLOGY, 2010, 74 (09) : A428 - A429
  • [32] Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients
    DeMarchi, S
    Falleti, E
    Giacomello, R
    Stel, G
    Cecchin, E
    Sepiacci, G
    Bortolotti, N
    Zanello, F
    Gonano, F
    Bartoli, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (08): : 1169 - 1177
  • [33] CARDIOVASCULAR RISK-FACTORS IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    COOPERMAN, M
    PFLUG, B
    MARTIN, EW
    EVANS, WE
    SURGERY, 1978, 84 (04) : 505 - 509
  • [34] Hemodynamic correlates of vascular risk factors in patients with Alzheimer's disease
    Yamazaki, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 368 - 368
  • [35] Prevalence and vascular risk factors of basal ganglia calcifications in patients at risk for cerebrovascular disease
    de Brouwer, Esther J. M.
    Kockelkoren, Remko
    De Vis, Jill B.
    Dankbaar, Jan Willem
    Velthuis, Birgitta K.
    Takx, Richard A. P.
    De Jonghe, Annemarieke
    Emmelot-Vonk, Marielle H.
    Koek, Huiberdina L.
    de Jong, Pim A.
    JOURNAL OF NEURORADIOLOGY, 2020, 47 (05) : 339 - 344
  • [36] Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys
    Gregoire, Laurent
    Smith, Tara
    Senanayake, Vijitha
    Mochizuki, Asuka
    Miville-Godbout, Edith
    Goodenowe, Dayan
    Di Paolo, Therese
    BEHAVIOURAL BRAIN RESEARCH, 2015, 286 : 328 - 337
  • [37] Catechol-O-methyltransferase inhibition with tolcapone reduces the ''wearing off'' phenomenon and levodopa requirements in fluctuating parkinsonian patients
    Baas, H
    Beiske, AG
    Ghika, J
    Jackson, M
    Oertel, WH
    Poewe, W
    Ransmayr, G
    Auff, E
    Volc, D
    Dupont, E
    Mikkelsen, B
    Wermuth, L
    WommPetersen, J
    Benecke, R
    Eichhom, T
    Kolbe, H
    Oertel, W
    Schimrigk, K
    Olsson, JE
    Palhagen, S
    Burgunder, JM
    Ghika, A
    Regli, F
    Steck, A
    Medcalf, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04): : 421 - 428
  • [38] Controlling Risk Factors Reduces Cancer Risk in Patients with Atherosclerotic Cardiovascular Disease: A Cohort Study
    Yue, Qing
    Yang, Ling
    Liu, Tong
    Feng, Baoyu
    Li, Yun
    Wang, Gang
    Wei, Zhihao
    Song, Zongshuang
    Zhao, Haiyan
    Wu, Shouling
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (04): : 341 - 349.e7
  • [39] Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations
    Rinne, UK
    Larsen, JP
    Siden, Å
    Worm-Petersen, J
    NEUROLOGY, 1998, 51 (05) : 1309 - 1314
  • [40] Choice reaction time after levodopa challenge in parkinsonian patients
    Müller, T
    Benz, S
    Przuntek, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 181 (1-2) : 98 - 103
12345